Stratos Wealth Partners, LTD. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 41 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2018. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q3 2018$10,000
-9.1%
5,150
-11.2%
0.00%
Q1 2018$11,0000.0%5,8000.0%0.00%
Q4 2017$11,0005,8000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$8,536,653,0002.90%
Glassman Wealth Services 72,366$137,0000.06%
B. Riley Wealth Management, Inc. 53,500$102,0000.02%
Sigma Planning Corp 223,400$424,0000.02%
Fore Capital, LLC 40,000$76,0000.02%
Psagot Value Holdings Ltd. 218,555$415,0000.02%
HBK Sorce Advisory LLC 85,500$162,0000.02%
WealthTrust Axiom LLC 10,000$19,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 12,894$24,0000.01%
Weiss Asset Management LP 29,691$56,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders